Copyright
©The Author(s) 2015.
World J Hepatol. Mar 27, 2015; 7(3): 406-424
Published online Mar 27, 2015. doi: 10.4254/wjh.v7.i3.406
Published online Mar 27, 2015. doi: 10.4254/wjh.v7.i3.406
Table 16 A prognostic model for hepatocellular carcinoma patients within the Milan criteria undergoing non‐transplant therapies
| Variables | Scores | ||
| 0 | 1 | 2 | |
| Total bilirubin (mg/dL) | < 1.5 | ≥ 1.5 | |
| AFP (ng/mL) | < 100 | ≥ 100 | |
| Ascites | - | Mild | Moderate to severe |
- Citation: Kinoshita A, Onoda H, Fushiya N, Koike K, Nishino H, Tajiri H. Staging systems for hepatocellular carcinoma: Current status and future perspectives. World J Hepatol 2015; 7(3): 406-424
- URL: https://www.wjgnet.com/1948-5182/full/v7/i3/406.htm
- DOI: https://dx.doi.org/10.4254/wjh.v7.i3.406